Difference between revisions of "CD61-75"
From Opengenome.net
| Line 63: | Line 63: | ||
<td><strong> CD65</strong></td> | <td><strong> CD65</strong></td> | ||
<td> </td> | <td> </td> | ||
| − | <td> </td> | + | <td> Ceramide-dodecasaccharide, VIM-2; glycolipid </td> |
| − | <td> </td> | + | <td> Myeloid cells </td> |
| − | <td> </td> | + | <td> Not known </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD65s</strong></td> | <td bgcolor="#cccccc"><strong> CD65s</strong></td> | ||
<td bgcolor="#cccccc"> </td> | <td bgcolor="#cccccc"> </td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Sialylated-CD65, VIM-2; carbohydrate </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Granulocytes, monocytes</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Possible involvement with phagocytosis and Ca 2+ influx </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD66a</strong></td> | <td><strong> CD66a</strong></td> | ||
| − | <td> </td> | + | <td> 160-180</td> |
| − | <td> </td> | + | <td> NCA-160, biliary glycoprotein (BGP) </td> |
| − | <td> </td> | + | <td> Granulocytes, epithelial cells</td> |
| − | <td> </td> | + | <td> Adhesion molecule; receptor for <em>Neisseria gonorrheae</em> and <em>N. meningitidis</em>; trigger of neutrophil activation </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD66b</strong></td> | <td bgcolor="#cccccc"><strong> CD66b</strong></td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 95-100</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> CD67, CGM6, NCA-95 </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Granulocytes</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Adhesion molecule; trigger of neutrophil activation </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD66c</strong></td> | <td><strong> CD66c</strong></td> | ||
| − | <td> </td> | + | <td> 90</td> |
| − | <td> </td> | + | <td> NCA, NCA-50/90 </td> |
| − | <td> </td> | + | <td> Granulocytes, epithelial cells </td> |
| − | <td> </td> | + | <td> Adhesion molecule; trigger of neutrophil activation </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD66d</strong></td> | <td bgcolor="#cccccc"><strong> CD66d</strong></td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 30</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> CGM1 </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Granulocytes</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Unclear; receptor for <em>Neisseria gonorrheae and N. meningitidis</em></td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD66e</strong></td> | <td><strong> CD66e</strong></td> | ||
| − | <td> </td> | + | <td> 180-200</td> |
| − | <td> </td> | + | <td> Carcinoembryonic antigen (CEA) </td> |
| − | <td> </td> | + | <td> Epithelial cells</td> |
| − | <td> </td> | + | <td> Unclear; possible adhesion molecule </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD66f</strong></td> | <td bgcolor="#cccccc"><strong> CD66f</strong></td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 54-72</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Pregnancy-specific b1 glycoprotein, SP-1, pregnancy-specific glycoprotein (PSG) </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Fetal liver; produced in placenta and released </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Unclear; possible involvement in immune regulation and protection of fetus from maternal immune system; necessary for successful pregnancy </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD68</strong></td> | <td><strong> CD68</strong></td> | ||
| − | <td> </td> | + | <td> 110</td> |
| − | <td> </td> | + | <td> gp110, macrosialin </td> |
| − | <td> </td> | + | <td> Monocytes, macrophages, dendritic cells, neutrophils, basophils, mast cells, myeloid progenitor cells, subset of CD34+ hematopoeitic progenitor cells, activated T cells, some peropheral-blood B cells </td> |
| − | <td> </td> | + | <td> Not known </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td bgcolor="#cccccc"><strong> CD69</strong></td> | <td bgcolor="#cccccc"><strong> CD69</strong></td> | ||
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> 60</td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Activation-inducer molecule (AIM), EA1, MLR3, gp34/28, very early activation (VEA) </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Activated leukocytes, inducing T cells, thymocytes, B cells, NK cells, neutrophils, eosinophils, and Langerhans cells; subset of mature thymocytes, germinal-center mantle B cells, some CD4+ germinal-center T cells </td> |
| − | <td bgcolor="#cccccc"> </td> | + | <td bgcolor="#cccccc"> Involvement in early events of lymphocyte, monocyte, and platelet activation: promotes Ca2+ influx, synthesis of cytokines and their receptors, induction of c-myc and c-fos proto-oncogene expression; role in promoting lysis mediated by activated NK cells </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td><strong> CD70</strong></td> | <td><strong> CD70</strong></td> | ||
| − | <td> </td> | + | <td> 75, 95, 170 </td> |
| − | <td> </td> | + | <td> CD27-ligand, Ki24 antigen </td> |
| − | <td> </td> | + | <td> Activated T and B cells and macrophages </td> |
| − | <td> </td> | + | <td> Ligand for CD27; possible role in co-stimulation of B and T cells </td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Revision as of 23:35, 7 September 2006
|
CD antigen |
MW.(kDa) |
Synonyms & Properties |
Leukocyte expression |
Function |
| CD61 | 110 | CD61A, GPⅡb/Ⅲa, β3 integrin chain | Platelets, megakaryocytes, macrophages | Integrin subunit, associates with CD41 (Gp11b/11a) or CD51 (vironectin receptor) |
| CD62E | 140 | E-selectin, ELAM-1, LECAM-2 | Acutely activated endothelium, chronic inflammatory lesions of skin and synovium | Adhesion molecule that mediates leukocyte rolling on activated endothelium at inflammatory sites |
| CD62L | 65 | L-selectin, LAM-1, LECAM-1, Leu-8, MEL-14, TQ-1 | Most peripheral-blood B cells, T cells, monocytes, granulocytes, NK cells; bone-marrow lymphocytes and myeloid cells, thymocytes | Adhesion molecule that mediates lymphocyte homing to high endothelial venules of peripheral lymphoid tissue and leukocyte rolling on activated endothelium at inflammatory sites |
| CD62P | 120 | P-selectin, granule membrane protein-140 (GMP-140), platelet activation-dependent granule-external membrane protein (PADGEM) | Endothelium, platelets, megakaryocytes | Interaction with PSGL-1 to mediate tethering and rolling of leukocytes on the surface of activated endothelial cells, the first step in leukocyte extravasation and migration toward sites of inflammation |
| CD63 | 40-60 | LIMP, MLA1, PTLGP40, gp55, granulophysin lysosomal-membrane-associated glycoprotein 3 (LAMP-3), melanoma-associated antigen (ME491), neuroglandular antigen (NGA) | Platelets, endothelium, degranulated neutrophils, monocytes, macrophages endothelium | Not known |
| CD64 | 72 | Fcγ\RI, FCRI | Monocytes, macrophages, bood and germinal-center dendritic cells, PMN activated by IFN-γ or G-CSF, early myeloid-lineage cells | Phagocytosis: receptor-mediated endocytosis of IgG-antigen complexes; antigen capture for presentation to T cells; antibody-dependent cellular cytotoxicity; mediator of release by some cells of cytokines and reactive oxygen intermediates |
| CD65 | Ceramide-dodecasaccharide, VIM-2; glycolipid | Myeloid cells | Not known | |
| CD65s | Sialylated-CD65, VIM-2; carbohydrate | Granulocytes, monocytes | Possible involvement with phagocytosis and Ca 2+ influx | |
| CD66a | 160-180 | NCA-160, biliary glycoprotein (BGP) | Granulocytes, epithelial cells | Adhesion molecule; receptor for Neisseria gonorrheae and N. meningitidis; trigger of neutrophil activation |
| CD66b | 95-100 | CD67, CGM6, NCA-95 | Granulocytes | Adhesion molecule; trigger of neutrophil activation |
| CD66c | 90 | NCA, NCA-50/90 | Granulocytes, epithelial cells | Adhesion molecule; trigger of neutrophil activation |
| CD66d | 30 | CGM1 | Granulocytes | Unclear; receptor for Neisseria gonorrheae and N. meningitidis |
| CD66e | 180-200 | Carcinoembryonic antigen (CEA) | Epithelial cells | Unclear; possible adhesion molecule |
| CD66f | 54-72 | Pregnancy-specific b1 glycoprotein, SP-1, pregnancy-specific glycoprotein (PSG) | Fetal liver; produced in placenta and released | Unclear; possible involvement in immune regulation and protection of fetus from maternal immune system; necessary for successful pregnancy |
| CD68 | 110 | gp110, macrosialin | Monocytes, macrophages, dendritic cells, neutrophils, basophils, mast cells, myeloid progenitor cells, subset of CD34+ hematopoeitic progenitor cells, activated T cells, some peropheral-blood B cells | Not known |
| CD69 | 60 | Activation-inducer molecule (AIM), EA1, MLR3, gp34/28, very early activation (VEA) | Activated leukocytes, inducing T cells, thymocytes, B cells, NK cells, neutrophils, eosinophils, and Langerhans cells; subset of mature thymocytes, germinal-center mantle B cells, some CD4+ germinal-center T cells | Involvement in early events of lymphocyte, monocyte, and platelet activation: promotes Ca2+ influx, synthesis of cytokines and their receptors, induction of c-myc and c-fos proto-oncogene expression; role in promoting lysis mediated by activated NK cells |
| CD70 | 75, 95, 170 | CD27-ligand, Ki24 antigen | Activated T and B cells and macrophages | Ligand for CD27; possible role in co-stimulation of B and T cells |
| CD71 | ||||
| CD72 | ||||
| CD73 | ||||
| CD74 | ||||
| CDw75 |
